|
🐜
|
Therapeutic effect of the combination of etanercept and methotrexate compared with each treatment alone in patients with rheumatoid arthritis: double-blind randomised controlled trial
14 auth.
L. Klareskog,
D. Heijde,
J. Jager,
A. Gough,
J. Kalden,
M. Malaise,
E. Mola,
K. Pavelka,
J. Sany,
L. Settas,
...
J. Wajdula,
R. Pedersen,
S. Fatenejad,
M. Sanda
|
10 |
2004 |
10
🐜
|
|
🐬
|
Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report.
J. Gómez-Reino,
L. Carmona,
V. Valverde,
E. Mola,
M. Montero
|
10 |
2003 |
10
🐬
|
|
🐜
|
Prevalence of comorbidities in rheumatoid arthritis and evaluation of their monitoring: results of an international, cross-sectional study (COMORA)
24 auth.
M. Dougados,
M. Soubrier,
A. Antunez,
P. Bálint,
A. Balsa,
M. Buch,
G. Casado,
J. Detert,
B. El-zorkany,
P. Emery,
...
N. Hajjaj-Hassouni,
M. Harigai,
S. Luo,
R. Kurucz,
G. Maciel,
E. Mola,
C. Montecucco,
I. McInnes,
H. Radner,
J. Smolen,
Y. Song,
H. Vonkeman,
K. Winthrop,
J. Kay
|
9 |
2013 |
9
🐜
|
|
🐜
|
Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists.
8 auth.
L. Carmona,
J. Gómez-Reino,
V. Rodríguez-valverde,
D. Montero,
E. Pascual-Gómez,
E. Mola,
...
L. Carreño,
M. Figueroa
|
9 |
2005 |
9
🐜
|
|
🐜
|
EULAR recommendations for the management of knee osteoarthritis: report of a task force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT)
24 auth.
A. Pendleton,
N. Arden,
M. Dougados,
M. Doherty,
B. Bannwarth,
J. Bijlsma,
F. Cluzeau,
C. Cooper,
P. Dieppe,
K. Gunther,
...
H. Hauselmann,
G. Herrero-Beaumont,
P. Kaklamanis,
B. Leeb,
M. Lequesne,
S. Lohmander,
B. Mazières,
E. Mola,
K. Pavelka,
U. Serni,
B. Swoboda,
A. Verbruggen,
G. Weseloh,
I. Zimmermann-Górska
|
9 |
2000 |
9
🐜
|
|
🐜
|
Current evidence for the management of rheumatoid arthritis with synthetic disease-modifying antirheumatic drugs: a systematic literature review informing the EULAR recommendations for the management of rheumatoid arthritis
9 auth.
C. Gaujoux-Viala,
J. Smolen,
R. Landewé,
M. Dougados,
T. Kvien,
E. Mola,
...
M. Scholte-Voshaar,
P. V. van Riel,
L. Gossec
|
8 |
2010 |
8
🐜
|
|
🐜
|
A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effects
8 auth.
V. Martínez-Taboada,
V. Rodríguez-valverde,
L. Carreño,
J. López‐Longo,
M. Figueroa,
J. Belzunegui,
...
E. Mola,
G. Bonilla
|
8 |
2007 |
8
🐜
|
|
🐜
|
Outcomes of a multicentre randomised clinical trial of etanercept to treat ankylosing spondylitis
20 auth.
A. Calin,
B. Dijkmans,
P. Emery,
M. Hakala,
J. Kalden,
M. Leirisalo-Repo,
E. Mola,
Carlo Salvarani,
R. Sanmartí,
J. Sany,
...
J. Sibilia,
J. Sieper,
S. Linden,
E. Veys,
A. Appel,
Saeed Fatenejad Disclaimer,
Ankylosing Spondylitis,
MD Raimon Sanmartí,
MD Sjet van der Linden,
MD Saeed Fatenejad
|
8 |
2004 |
8
🐜
|
|
🐜
|
Finalisation and validation of the rheumatoid arthritis impact of disease score, a patient-derived composite measure of impact of rheumatoid arthritis: a EULAR initiative
23 auth.
L. Gossec,
S. Paternotte,
G. J. Aanerud,
A. Balanescu,
D. Boumpas,
L. Carmona,
M. Wit,
B. Dijkmans,
M. Dougados,
M. Englbrecht,
...
F. Gogus,
T. Heiberg,
C. Hernandez,
J. Kirwan,
E. Mola,
M. Cerinic,
K. Otsa,
G. Schett,
M. Scholte-Voshaar,
T. Sokka,
G. Krause,
G. Wells,
T. Kvien
|
8 |
2011 |
8
🐜
|
|
🐜
|
Elaboration of the preliminary Rheumatoid Arthritis Impact of Disease (RAID) score: a EULAR initiative
31 auth.
L. Gossec,
M. Dougados,
N. Rincheval,
A. Balanescu,
D. Boumpas,
S. Canadelo,
L. Carmona,
J. Daurès,
M. Wit,
B. Dijkmans,
M. Englbrecht,
Z. Gunendi,
T. Heiberg,
J. Kirwan,
E. Mola,
...
M. Matucci-Cerinic,
K. Otsa,
G. Schett,
T. Sokka,
G. Wells,
G. J. Aanerud,
A. Celano,
A. Dudkin,
C. Hernandez,
K. Koutsogianni,
F. Akça,
A. Pêtre,
P. Richards,
M. Scholte-Voshaar,
G. Krause,
T. Kvien
|
7 |
2008 |
7
🐜
|
|
🐜
|
Clinical, radiographic and immunogenic effects after 1 year of tocilizumab-based treatment strategies in rheumatoid arthritis: the ACT-RAY study
12 auth.
M. Dougados,
K. Kissel,
P. Conaghan,
E. Mola,
G. Schett,
R. Gerli,
...
M. Hansen,
H. Amital,
R. Xavier,
O. Troum,
C. Bernasconi,
T. Huizinga
|
7 |
2014 |
7
🐜
|
|
🐜
|
Low Vitamin D Levels in Outpatient Postmenopausal Women from a Rheumatology Clinic in Madrid, Spain: Their Relationship with Bone Mineral Density
9 auth.
Pilar Aguado,
M. Campo,
M. Garcés,
M. González-Casaus,
M. Bernad,
J. Gijón-Baños,
...
E. Mola,
A. Torrijos,
M. E. Martínez
|
7 |
2000 |
7
🐜
|
